Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: Czechia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20063
20075
20082
20091
20111
20131
20141
20154
20181
20193
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Boehringer Ingelheim4
Acorda Therapeutics3
GlaxoSmithKline3
Impax Laboratories, LLC2
Kyowa Kirin Co., Ltd.2
Solvay Pharmaceuticals2
AbbVie (prior sponsor, Abbott)1
Biotie Therapies Inc.1
Cerevance1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease28
Dyskinesias5
Brain Diseases3
Central Nervous System Diseases3
Movement Disorders3
Nervous System Diseases3
Neurodegenerative Diseases3
Parkinsonian Disorders3
Pain1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.